Fieldpoint Private Securities’s Zimmer Biomet ZBH Stock Holding History

Fieldpoint Private Securities’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$99K	Sell	945 -45	-5%	-$5.34K	0.03%	370
2022 Q1	$127K	Sell	990 -95	-9%	-$11.5K	0.03%	388
2021 Q4	$134K	Sell	1,085 -10	-0.9%	-$1.31K	0.03%	385
2021 Q3	$156K	Buy	1,095 +36	+3%	+$5.3K	0.03%	350
2021 Q2	$150K	Sell	1,059 -55	-5%	-$8.91K	0.03%	350
2021 Q1	$173K	Buy	1,114 +5	+0.5%	+$775	0.04%	306
2020 Q4	$166K	Buy	+1,109	New	+$157K	0.04%	313
2020 Q3	–	Sell	-2,641	Closed	-$306K	–	285
2020 Q2	$306K	Buy	+2,641	New	+$304K	0.1%	188
2020 Q1	–	Sell	-1,030	Closed	-$150K	–	584
2019 Q4	$150K	Sell	1,030 -105	-9%	-$14.5K	0.04%	296
2019 Q3	$151K	Hold	1,135	–	–	0.05%	240
2019 Q2	$130K	Buy	1,135 +105	+10%	+$12.3K	0.04%	287
2019 Q1	$128K	Hold	1,030	–	–	0.05%	226
2018 Q4	$104K	Hold	1,030	–	–	0.05%	234
2018 Q3	$131K	Hold	1,030	–	–	0.05%	240
2018 Q2	$111K	Hold	1,030	–	–	0.04%	253
2018 Q1	$109K	Hold	1,030	–	–	0.05%	231
2017 Q4	$121K	Sell	1,030 -281	-21%	-$31.8K	0.06%	212
2017 Q3	$149K	Buy	1,311 +281	+27%	+$32.4K	0.06%	220
2017 Q2	$128K	Hold	1,030	–	–	0.09%	81
2017 Q1	$122K	Buy	+1,030	New	+$117K	0.09%	131

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fieldpoint Private Securities's ZBH Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Zimmer Biomet (ZBH) stake by 4.5% in Q2 2022, selling an estimated $5.34K and leaving 945 shares worth $99K. The position accounts for 0.03% of the portfolio, ranked #370.

Fieldpoint Private Securities first reported a position in ZBH in Q1 2017 and has held it in 20 quarters since. The position peaked at $306K in Q2 2020. 957 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

Fieldpoint Private Securities held 945 shares of Zimmer Biomet worth $99K as of Q2 2022.
Fieldpoint Private Securities sold 45 Zimmer Biomet shares in Q2 2022, an estimated $5.34K.
Zimmer Biomet made up 0.03% of Fieldpoint Private Securities's portfolio in Q2 2022, its #370 holding.
Fieldpoint Private Securities first reported a position in Zimmer Biomet in Q1 2017 and has held it in 20 quarters since.
Fieldpoint Private Securities's Zimmer Biomet position peaked at $306K in Q2 2020.
957 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.